Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $847.6800 (0.72%) ($847.6800 - $847.6800) on Sat. Dec. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.14% (three month average) | RSI | 63 | Latest Price | $847.6800(0.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting REGN price | REGN will decline at least -0.57% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.57% (StdDev 1.14%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $846.09(0.19%) | 10 Day Moving Average | $854.5(-0.8%) | 20 Day Moving Average | $839.22(1.01%) | To recent high | -3.3% | To recent low | 9.4% | Market Cap | $N/A | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |